Seroatlas · Human Serome Atlas

ANXA8

Annexin A8

Also known as: ANX8, ANXA8_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P13928
Gene
ANXA8
Ensembl
ENSG00000265190
Chromosome
10
Canonical length
327 aa
Protein class
Predicted intracellular proteins
Subcellular location
Vesicles

OverviewNCBI Gene

This gene encodes a member of the annexin family of evolutionarily conserved Ca2+ and phospholipid binding proteins. The encoded protein may function as an an anticoagulant that indirectly inhibits the thromboplastin-specific complex. Overexpression of this gene has been associated with acute myelocytic leukemia. A highly similar duplicated copy of this gene is found in close proximity on the long arm of chromosome 10. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

327 residues, UniProt reviewed canonical sequence.

>P13928|ANXA8
     1  MAWWKSWIEQ EGVTVKSSSH FNPDPDAETL YKAMKGIGTN EQAIIDVLTK RSNTQRQQIA
    61  KSFKAQFGKD LTETLKSELS GKFERLIVAL MYPPYRYEAK ELHDAMKGLG TKEGVIIEIL
   121  ASRTKNQLRE IMKAYEEDYG SSLEEDIQAD TSGYLERILV CLLQGSRDDV SSFVDPGLAL
   181  QDAQDLYAAG EKIRGTDEMK FITILCTRSA THLLRVFEEY EKIANKSIED SIKSETHGSL
   241  EEAMLTVVKC TQNLHSYFAE RLYYAMKGAG TRDGTLIRNI VSRSEIDLNL IKCHFKKMYG
   301  KTLSSMIMED TSGDYKNALL SLVGSDP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ANXA8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.25
Highest tissue expression
252 nTPM

Expression across tissuesHPA

Tissue

  • skin: 252 nTPM
  • esophagus: 175 nTPM
  • vagina: 88 nTPM
  • cervix: 65 nTPM
  • adipose tissue: 63 nTPM
  • urinary bladder: 62 nTPM

Single-cell type

  • suprabasal keratinocytes: 92 nCPM
  • esophageal suprabasal cells: 68 nCPM
  • epicardial cells: 64 nCPM
  • basal keratinocytes: 57 nCPM
  • mesothelial cells: 51 nCPM
  • ocular epithelial cells: 41 nCPM

Immune cell

  • myeloid DC: 1.6 nTPM
  • classical monocyte: 0.5 nTPM
  • eosinophil: 0.2 nTPM
  • total PBMC: 0.2 nTPM
  • NK-cell: 0.1 nTPM
  • basophil: 0 nTPM

Brain region

  • hypothalamus: 3.2 nTPM
  • cerebral cortex: 2.6 nTPM
  • medulla oblongata: 2.4 nTPM
  • white matter: 2 nTPM
  • midbrain: 1.9 nTPM
  • cerebellum: 1.6 nTPM

ReferencesPubMed · IEDB

Publications for ANXA8 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

2 publications

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

DepMap mean gene effect
-0.05
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ANXA8 as an antibody target. Whether an autoantibody or antibody against ANXA8 could matter depends on whether native ANXA8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ANXA8 is annotated at the cell surface, where native ANXA8 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label ANXA8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ANXA8. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...